Tandem Diabetes Care Reports Q3 Revenue and EPS Beat
Tandem Diabetes Care (TNDM) reported third-quarter financial results that exceeded market expectations for both top and bottom lines. The company posted revenue of $283.7 million, representing a 13.8% increase year-over-year and beating estimates by $17.85 million. Despite reporting a GAAP EPS loss of $0.10 per share, the figure outperformed analyst projections by $0.15. The company also provided guidance on gross margins, estimating them to be between 56% and 57% of sales for the period.
Tickers: $TNDM
Topics: earnings beat gross margin revenue growth